Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

NCT04168099 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Spontaneous Bacterial Peritonitis

Interventions

DRUG: Cefotaxime
DRUG: Gemifloxacin

Sponsor

Tanta University